InterCure Ltd. (TASE:INCR) entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd on January 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
999.9 ILa | +0.77% | +5.81% | +115.91% |
Apr. 01 | InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023 | CI |
Mar. 22 | InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+115.91% | 119M | |
+27.84% | 272M | |
+37.45% | 261M | |
+47.09% | 194M | |
+43.15% | 131M | |
-28.57% | 121M | |
-37.75% | 119M | |
+3.85% | 86.82M | |
+150.00% | 75.33M | |
+3.61% | 55.24M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd.